Research Overview: SP Cabergolin 0.25mg SP Laboratory
SP Cabergolin 0.25mg is a pharmaceutical-grade dopamine D2 receptor agonist manufactured by SP Laboratory specifically for controlled research environments. This ergoline derivative demonstrates significant potential in laboratory studies examining prolactin suppression mechanisms and hypothalamic-pituitary axis regulation. Researchers at Stroid UK Shop utilise this compound to investigate endocrine system responses and neurochemical pathways. SP Laboratory maintains rigorous manufacturing standards, ensuring each batch meets analytical specifications required for precise experimental protocols.
Laboratory Research Applications
Scientific investigations with SP Cabergolin 0.25mg focus primarily on prolactin regulation studies and dopaminergic pathway research. Laboratory protocols examine this compound’s interaction with D2 receptors in cellular models, providing insights into neurotransmitter signalling mechanisms. Research teams investigate its potential applications alongside other compounds available in our comprehensive PCT research collection. Studies often examine comparative efficacy against other research compounds, including those found in our SARM research catalogue and peptide research inventory. Analytical research focuses on bioavailability studies, receptor binding affinity measurements, and pharmacokinetic profiling in controlled laboratory settings.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Cabergoline |
| Concentration | 0.25mg per unit |
| Manufacturer | SP Laboratory |
| Molecular Formula | C26H37N5O2 |
| Molecular Weight | 451.6 g/mol |
| CAS Number | 81409-90-7 |
| Storage Requirements | Cool, dry conditions |
| Research Applications | Prolactin studies, dopamine research |
Research Compliance Statement
SP Cabergolin 0.25mg SP Laboratory is manufactured exclusively for in-vitro research purposes and scientific investigation protocols. This product is not intended for human consumption, therapeutic use, or any applications outside controlled laboratory environments. Researchers must ensure appropriate safety protocols and analytical procedures when handling this compound. All investigations should comply with institutional research guidelines and applicable scientific standards for compound evaluation studies.
